Abbott India September quarter revenue rises 11%, profit rises 9%
ABBOTINDIA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
On a standalone basis for the quarter ended September 30, 2026, revenue from operations was Rs 1,951.01 crore versus Rs 1,757.15 crore a year earlier, up 11.0%, while profit was Rs 453.45 crore versus Rs 415.27 crore, up 9.2%. For the standalone half year then ended, revenue was Rs 3,764.69 crore and profit Rs 881.97 crore; operating cash flow was positive at Rs 658.97 crore. The limited review report had no qualifications.
Revenue and profit growth and positive operating cash flow are positive for shareholders, though the increases were moderate rather than a major earnings jump.
The filed figures for this quarter have not reached us in XBRL yet, so there is nothing to compute here; the read above is the AI's, from the document. The table appears the moment the figures land.